General Information of Drug (ID: DMTCR2O)

Drug Name
Tecarfarin Drug Info
Synonyms ATI-5923
Indication
Disease Entry ICD 11 Status REF
Cerebrovascular ischaemia 8B1Z Phase 3 [1]
Thrombosis DB61-GB90 Phase 3 [2]
Cross-matching ID
PubChem CID
54718618
CAS Number
CAS 867257-26-9
TTD Drug ID
DMTCR2O

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Approved Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Warfarin DMJYCVW Atrial fibrillation BC81.3 Approved [4]
Acenocoumarol DMH75KV Thrombosis DB61-GB90 Approved [5]
Phenprocoumon DMDO279 Myocardial infarction BA41-BA43 Approved [4]
Dicumarol DMFQCB1 Bleeding disorder GA20-GA21 Approved [6]
Phenindione DM2PYNR Coagulation defect 3B10.0 Approved [4]

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Vitamin K epoxide reductase complex 1 (VKORC1) TTEUC8H VKOR1_HUMAN Inhibitor [3]

References

1 ClinicalTrials.gov (NCT02522221) Tecarfarin Anti-Coagulation Trial (TACT).
2 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
3 Tecarfarin, a novel vitamin K reductase antagonist, is not affected by CYP2C9 and CYP3A4 inhibition following concomitant administration of fluconazole in healthy participants. J Clin Pharmacol. 2011Apr;51(4):561-74.
4 [Oral anticoagulation and pharmacogenetics: importance in the clinical setting]. Rev Med Suisse. 2007 Sep 12;3(124):2030, 2033-4, 2036.
5 Evaluation of a reverse-hybridization StripAssay for the detection of genetic polymorphisms leading to acenocoumarol sensitivity. Mol Biol Rep. 2010 Apr;37(4):1693-7.
6 Vitamin K antagonism of coumarin intoxication in the rat. Thromb Haemost. 1986 Apr 30;55(2):235-9.